Julie B. Friedman

Julie has over 25 years of experience in the Pharma/Biotech sector. She joined Iconic from Quark Pharmaceuticals where she was the VP of Alliance and Program Management responsible for driving and managing the R&D Portfolio and all partner relationships.

Previous to this Julie worked in both small and large Pharma/Biotech companies. She has managed programs from Lead Candidate Identification through commercial launch at Medivation, Genentech, Takeda, and Bristol-Myers Squibb, heading programs with annual budgets of $25-100 million/year. Julie co-lead the successful filing for Medivation’s Extandi® sNDA. She managed major alliances at Quark, Medivation and Genentech with Roche, Biocon, Astellas and Merk Serono. Julie has been involved in professional organizations such as the Sigma Theta Tau (Alpha Chapter) Nursing honor society, the Industry Pharmacogenomics Working Group I-PWG (as Chairman in 2002-2003), the Association of Strategic Alliance Professionals and the Bay Area Biopharma Project Management.

Starting her career as an ICU Nurse, she moved to the Public Health sector for both the US Centers for Disease Control and the Israeli Ministry of Health. Julie holds and Master of Public Health in International Public Health from Emory University and a Bachelor of Science in Nursing from Indiana University.